Align Technology Inc(ALGN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:20 PM ET (Korea 9/12 05:20)
Full metrics table
| Index | S&P 500 | P/E | 26.16 | EPS (ttm) | 5.76 | Insider Own | 3.32% | Shs Outstand | 71.3M | Perf Week | -5.65% |
| Market Cap | 10.71B | Forward P/E | 12.03 | EPS next Y | 11.05% | Insider Trans | - | Shs Float | 68.7M | Perf Month | -13.33% |
| Enterprise Value | 9.73B | PEG | 1.27 | EPS next Q | 2.8 | Inst Own | 105.24% | Short Float | 5.62% | Perf Quarter | -14.55% |
| Income | 0.41B | P/S | 2.59 | EPS this Y | 7.44% | Inst Trans | 2.89% | Short Ratio | 4.03 | Perf Half Y | -9.65% |
| Sales | 4.14B | P/B | 2.54 | EPS next 5Y | 9.46% | ROA | 6.55% | Short Interest | 3.86M | Perf YTD | -3.41% |
| Book/sh | 59.41 | P/C | 9.72 | EPS past 3/5Y | 7.03% -24.08% | ROE | 10.16% | 52W High | -24.75% ($200.43) | Perf Year | 10.97% |
| Cash/sh | 15.52 | P/FCF | 16.91 | Sales past 3/5Y | 2.61% 10.3% | ROIC | 9.58% | 52W Low | 23.62% ($122.00) | Perf 3Y | -55% |
| Dividend Est. | - | EV/EBITDA | 10.27 | EPS Y/Y TTM | -2.69% | Gross Margin | 70.65% | Volatility(W/M) | 2.68% 3.22% | Perf 5Y | -79.07% |
| Dividend TTM | - | EV/Sales | 2.35 | Sales Y/Y TTM | 4.41% | Oper. Margin | 18.38% | ATR (14) | 5.47 | Perf 10Y | 64.31% |
| Dividend Ex-Date | - | Quick Ratio | 1.28 | EPS Q/Q | -11.79% | Profit Margin | 9.99% | RSI (14) | 34.35 | Recom | 2.05 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.4 | Sales Q/Q | 4.32% | SMA20 | -5.74% ($160) | Beta | 1.67 | Target Price | $209.57 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2026/7/29 | SMA50 | -11.03% ($169.52) | Rel Volume | 0.65 | Prev Close | $150.72 |
| Employees | 20290 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 0.91% 0.4% | SMA200 | -11.74% ($170.88) | Avg Volume(3M) | 0.96M | Price | $150.82 |
| IPO | 2001/1/26 | Option/Short | Yes/Yes | Trades | 11829 | Volume | 619,669 | Change | 0.07% |
Company
ALGN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US dental medical device company that develops and supplies clear aligners (Invisalign) and intraoral scanners, digitizing the orthodontic market as a global clear aligner and digital dental solutions company, and a pioneer in the clear aligner field.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
ALGN makes money exceptionally well
18.38% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.4% this year.
Tap to view numbers
The price looks about right
Trading at 26.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -55.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 105.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
CAMX 0.04%
KMID 0.04%
EKG 0.03%
PINK 0.03%
LGHT 0.03%It ranks #4 in the industry
Based on market cap of $11B.
ALGN $11B PER 26.2
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is ALGN?
ALGN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ALGN?
The market cap of ALGN is approximately $10.7B, ranking 903 within its sector.
What is the P/E ratio of ALGN?
ALGN has a P/E ratio of approximately 26.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALGN?
ALGN has recorded a 52-week high of $200.43 and a low of $122.00.
